Interest of designed cyclodextrin-tools in gene delivery☆
Identifieur interne : 000805 ( Pmc/Curation ); précédent : 000804; suivant : 000806Interest of designed cyclodextrin-tools in gene delivery☆
Auteurs : R.-E. Duval ; I. Clarot ; F. Dumarcay-Charbonnier ; S. Fontanay ; A. MarsuraSource :
- Annales Pharmaceutiques Francaises [ 0003-4509 ] ; 2012.
Abstract
Cyclodextrins (CyDs) currently displays even today the image of a natural macrocyclic compound largely dominant in the formation of inclusion complexes with small hydrophobic molecules. During the past 10 years, advances in this field allowed to achieve more and more sophisticated CyDs derivatives opening a simple access in scale-up quantities to original and better CyD-based gene delivery systems. In addition, possibility to combine covalent and supramolecular approaches offers new venues for the design of tailor-made CyD-based nanovehicles to improve their transfection ability and gene transfer in cells. In this account, we describe our recent progress in the construction of a novel CyD-based G0 (generation number) core dendrimer, scalable to CyD oligomers by a strategy using protonable guanidine tethers and whose concept can be generalized for the assembly of CyD pre-coated dendrimers. The synthetic strategy based on an original Staudinger-Aza-Wittig tandem coupling reaction. We present an outline of the different analytical strategies to characterize CyD-ODN (cyclodextrin-oligodeoxynucleotide) complexes. Among them, Capillary electrophoresis (CE) was used to perfectly characterize our CyD-siRNA and CyD-DNA complexes and shown to be a very attractive method with advantages of low sample consumption, rapid analysis speed, and high efficiency that make this technology a major tool for association constant measurement. Finally, we present the different biological methods that can be used, in vitro, to study gene delivery, and more precisely ones we have performed to evaluate the capability of our original model bis-guanidinium-tetrakis-β-cyclodextrin dendrimeric tetrapod, to deliver efficiently DNA or siRNA in eukaryotic cells.
Url:
DOI: 10.1016/j.pharma.2012.09.005
PubMed: 23177563
PubMed Central: 7094360
Links toward previous steps (curation, corpus...)
- to stream Pmc, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000805
Links to Exploration step
PMC:7094360Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Interest of designed cyclodextrin-tools in gene delivery<sup><xref ref-type="fn" rid="d32e884">☆</xref></sup></title><author><name sortKey="Duval, R E" sort="Duval, R E" uniqKey="Duval R" first="R.-E." last="Duval">R.-E. Duval</name></author><author><name sortKey="Clarot, I" sort="Clarot, I" uniqKey="Clarot I" first="I." last="Clarot">I. Clarot</name></author><author><name sortKey="Dumarcay Charbonnier, F" sort="Dumarcay Charbonnier, F" uniqKey="Dumarcay Charbonnier F" first="F." last="Dumarcay-Charbonnier">F. Dumarcay-Charbonnier</name></author><author><name sortKey="Fontanay, S" sort="Fontanay, S" uniqKey="Fontanay S" first="S." last="Fontanay">S. Fontanay</name></author><author><name sortKey="Marsura, A" sort="Marsura, A" uniqKey="Marsura A" first="A." last="Marsura">A. Marsura</name></author></titleStmt><publicationStmt><idno type="wicri:source">PMC</idno><idno type="pmid">23177563</idno><idno type="pmc">7094360</idno><idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7094360</idno><idno type="RBID">PMC:7094360</idno><idno type="doi">10.1016/j.pharma.2012.09.005</idno><date when="2012">2012</date><idno type="wicri:Area/Pmc/Corpus">000805</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000805</idno><idno type="wicri:Area/Pmc/Curation">000805</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">000805</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Interest of designed cyclodextrin-tools in gene delivery<sup><xref ref-type="fn" rid="d32e884">☆</xref></sup></title><author><name sortKey="Duval, R E" sort="Duval, R E" uniqKey="Duval R" first="R.-E." last="Duval">R.-E. Duval</name></author><author><name sortKey="Clarot, I" sort="Clarot, I" uniqKey="Clarot I" first="I." last="Clarot">I. Clarot</name></author><author><name sortKey="Dumarcay Charbonnier, F" sort="Dumarcay Charbonnier, F" uniqKey="Dumarcay Charbonnier F" first="F." last="Dumarcay-Charbonnier">F. Dumarcay-Charbonnier</name></author><author><name sortKey="Fontanay, S" sort="Fontanay, S" uniqKey="Fontanay S" first="S." last="Fontanay">S. Fontanay</name></author><author><name sortKey="Marsura, A" sort="Marsura, A" uniqKey="Marsura A" first="A." last="Marsura">A. Marsura</name></author></analytic><series><title level="j">Annales Pharmaceutiques Francaises</title><idno type="ISSN">0003-4509</idno><idno type="eISSN">0003-4509</idno><imprint><date when="2012">2012</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><title>Summary</title><p>Cyclodextrins (CyDs) currently displays even today the image of a natural macrocyclic compound largely dominant in the formation of inclusion complexes with small hydrophobic molecules. During the past 10 years, advances in this field allowed to achieve more and more sophisticated CyDs derivatives opening a simple access in scale-up quantities to original and better CyD-based gene delivery systems. In addition, possibility to combine covalent and supramolecular approaches offers new venues for the design of tailor-made CyD-based nanovehicles to improve their transfection ability and gene transfer in cells. In this account, we describe our recent progress in the construction of a novel CyD-based G0 (generation number) core dendrimer, scalable to CyD oligomers by a strategy using protonable guanidine tethers and whose concept can be generalized for the assembly of CyD pre-coated dendrimers. The synthetic strategy based on an original Staudinger-Aza-Wittig tandem coupling reaction. We present an outline of the different analytical strategies to characterize CyD-ODN (cyclodextrin-oligodeoxynucleotide) complexes. Among them, Capillary electrophoresis (CE) was used to perfectly characterize our CyD-siRNA and CyD-DNA complexes and shown to be a very attractive method with advantages of low sample consumption, rapid analysis speed, and high efficiency that make this technology a major tool for association constant measurement. Finally, we present the different biological methods that can be used, in vitro, to study gene delivery, and more precisely ones we have performed to evaluate the capability of our original model bis-guanidinium-tetrakis-β-cyclodextrin dendrimeric tetrapod, to deliver efficiently DNA or siRNA in eukaryotic cells.</p></div></front><back><div1 type="bibliography"><listBibl><biblStruct><analytic><author><name sortKey="Boussif, O" uniqKey="Boussif O">O. Boussif</name></author><author><name sortKey="Lezoualc, F" uniqKey="Lezoualc F">F. Lezoualc’h</name></author><author><name sortKey="Zanta, M A" uniqKey="Zanta M">M.A. Zanta</name></author><author><name sortKey="Mergny, M D" uniqKey="Mergny M">M.D. Mergny</name></author><author><name sortKey="Scherman, D" uniqKey="Scherman D">D. Scherman</name></author><author><name sortKey="Demeneix, B" uniqKey="Demeneix B">B. Demeneix</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Felgner, P L" uniqKey="Felgner P">P.L. Felgner</name></author><author><name sortKey="Barenhol, Y" uniqKey="Barenhol Y">Y. Barenhol</name></author><author><name sortKey="Behr, J P" uniqKey="Behr J">J.-P. Behr</name></author><author><name sortKey="Cheng, S H" uniqKey="Cheng S">S.H. Cheng</name></author><author><name sortKey="Cullis, P" uniqKey="Cullis P">P. Cullis</name></author><author><name sortKey="Huang, L" uniqKey="Huang L">L. Huang</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Vijayanathan, V" uniqKey="Vijayanathan V">V. Vijayanathan</name></author><author><name sortKey="Thomas, T" uniqKey="Thomas T">T. Thomas</name></author><author><name sortKey="Thomas, T J" uniqKey="Thomas T">T.J. Thomas</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Fischer, D" uniqKey="Fischer D">D. Fischer</name></author><author><name sortKey="Von Harpe, A" uniqKey="Von Harpe A">A. von Harpe</name></author><author><name sortKey="Kunath, K" uniqKey="Kunath K">K. Kunath</name></author><author><name sortKey="Petersen, H" uniqKey="Petersen H">H. Petersen</name></author><author><name sortKey="Li, Y X" uniqKey="Li Y">Y.X. Li</name></author><author><name sortKey="Kissel, T" uniqKey="Kissel T">T. Kissel</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Kim, T I" uniqKey="Kim T">T.I. Kim</name></author><author><name sortKey="Seo, H J" uniqKey="Seo H">H.J. Seo</name></author><author><name sortKey="Choi, J S" uniqKey="Choi J">J.S. Choi</name></author><author><name sortKey="Jang, H S" uniqKey="Jang H">H.S. Jang</name></author><author><name sortKey="Baek, J U" uniqKey="Baek J">J.U. Baek</name></author><author><name sortKey="Kim, K" uniqKey="Kim K">K. Kim</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Luo, D" uniqKey="Luo D">D. Luo</name></author><author><name sortKey="Saltzman, W M" uniqKey="Saltzman W">W.M. Saltzman</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Tang, M X" uniqKey="Tang M">M.X. Tang</name></author><author><name sortKey="Szoka, F C" uniqKey="Szoka F">F.C. Szoka</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Pun, S H" uniqKey="Pun S">S.H. Pun</name></author><author><name sortKey="Davis, M E" uniqKey="Davis M">M.E. Davis</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Pun, S H" uniqKey="Pun S">S.H. Pun</name></author><author><name sortKey="Bellocq, N C" uniqKey="Bellocq N">N.C. Bellocq</name></author><author><name sortKey="Liu, A J" uniqKey="Liu A">A.J. Liu</name></author><author><name sortKey="Jensen, G" uniqKey="Jensen G">G. Jensen</name></author><author><name sortKey="Machemer, T" uniqKey="Machemer T">T. Machemer</name></author><author><name sortKey="Quijano, E" uniqKey="Quijano E">E. Quijano</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Loftsson, T" uniqKey="Loftsson T">T. Loftsson</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Lehn, J M" uniqKey="Lehn J">J.M. Lehn</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Zhao, Q Y" uniqKey="Zhao Q">Q.Y. Zhao</name></author><author><name sortKey="Temsamani, J" uniqKey="Temsamani J">J. Temsamani</name></author><author><name sortKey="Agrawal, S" uniqKey="Agrawal S">S. Agrawal</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Hirayama, F" uniqKey="Hirayama F">F. Hirayama</name></author><author><name sortKey="Uekama, K" uniqKey="Uekama K">K. Uekama</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Redenti, E" uniqKey="Redenti E">E. Redenti</name></author><author><name sortKey="Pietra, C" uniqKey="Pietra C">C. Pietra</name></author><author><name sortKey="Gerloczy, A" uniqKey="Gerloczy A">A. Gerloczy</name></author><author><name sortKey="Szente, L" uniqKey="Szente L">L. Szente</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Cserhati, T" uniqKey="Cserhati T">T. Cserhati</name></author><author><name sortKey="Forgac, E" uniqKey="Forgac E">E. Forgac</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Abdou, S" uniqKey="Abdou S">S. Abdou</name></author><author><name sortKey="Collomb, J" uniqKey="Collomb J">J. Collomb</name></author><author><name sortKey="Sallas, F" uniqKey="Sallas F">F. Sallas</name></author><author><name sortKey="Marsura, A" uniqKey="Marsura A">A. Marsura</name></author><author><name sortKey="Finance, C" uniqKey="Finance C">C. Finance</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Ortiz Mellet, C" uniqKey="Ortiz Mellet C">C. Ortiz Mellet</name></author><author><name sortKey="Garcia Fernandez, J M" uniqKey="Garcia Fernandez J">J.M. Garcia Fernandez</name></author><author><name sortKey="Benito, J M" uniqKey="Benito J">J.M. Benito</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Menuel, S" uniqKey="Menuel S">S. Menuel</name></author><author><name sortKey="Duval, R E" uniqKey="Duval R">R.E. Duval</name></author><author><name sortKey="Cuc, D" uniqKey="Cuc D">D. Cuc</name></author><author><name sortKey="Mutzenhardt, P" uniqKey="Mutzenhardt P">P. Mutzenhardt</name></author><author><name sortKey="Marsura, A" uniqKey="Marsura A">A. Marsura</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Hansen, L D" uniqKey="Hansen L">L.D. Hansen</name></author><author><name sortKey="Fellingham, G W" uniqKey="Fellingham G">G.W. Fellingham</name></author><author><name sortKey="Russell, D J" uniqKey="Russell D">D.J. Russell</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Menuel, S" uniqKey="Menuel S">S. Menuel</name></author><author><name sortKey="Fontanay, S" uniqKey="Fontanay S">S. Fontanay</name></author><author><name sortKey="Clarot, I" uniqKey="Clarot I">I. Clarot</name></author><author><name sortKey="Duval, R E" uniqKey="Duval R">R.E. Duval</name></author><author><name sortKey="Diez, L" uniqKey="Diez L">L. Diez</name></author><author><name sortKey="Marsura, A" uniqKey="Marsura A">A. Marsura</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Jiang, C" uniqKey="Jiang C">C. Jiang</name></author><author><name sortKey="Armstrong, D W" uniqKey="Armstrong D">D.W. Armstrong</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="He, X" uniqKey="He X">X. He</name></author><author><name sortKey="Ding, Y" uniqKey="Ding Y">Y. Ding</name></author><author><name sortKey="Li, D" uniqKey="Li D">D. Li</name></author><author><name sortKey="Lin, B" uniqKey="Lin B">B. Lin</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Tanaka, Y" uniqKey="Tanaka Y">Y. Tanaka</name></author><author><name sortKey="Terabe, S" uniqKey="Terabe S">S. Terabe</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Guthrie, J W" uniqKey="Guthrie J">J.W. Guthrie</name></author><author><name sortKey="Ryu, J H" uniqKey="Ryu J">J.-H. Ryu</name></author><author><name sortKey="Le, X C" uniqKey="Le X">X.C. Le</name></author><author><name sortKey="Wiebe, L I" uniqKey="Wiebe L">L.I. Wiebe</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Yu, L P" uniqKey="Yu L">L.P. Yu</name></author><author><name sortKey="Sun, Y Z" uniqKey="Sun Y">Y.Z. Sun</name></author><author><name sortKey="Zhao, Z X" uniqKey="Zhao Z">Z.X. Zhao</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Mosmann, T" uniqKey="Mosmann T">T. Mosmann</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Borenfreund, E" uniqKey="Borenfreund E">E. Borenfreund</name></author><author><name sortKey="Puerner, J A" uniqKey="Puerner J">J.A. Puerner</name></author></analytic></biblStruct></listBibl></div1></back></TEI><pmc article-type="research-article"><pmc-dir>properties open_access</pmc-dir>
<front><journal-meta><journal-id journal-id-type="nlm-ta">Ann Pharm Fr</journal-id><journal-id journal-id-type="iso-abbrev">Ann Pharm Fr</journal-id><journal-title-group><journal-title>Annales Pharmaceutiques Francaises</journal-title></journal-title-group><issn pub-type="ppub">0003-4509</issn><issn pub-type="epub">0003-4509</issn><publisher><publisher-name>Elsevier Masson Editeur</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">23177563</article-id><article-id pub-id-type="pmc">7094360</article-id><article-id pub-id-type="publisher-id">S0003-4509(12)00144-7</article-id><article-id pub-id-type="doi">10.1016/j.pharma.2012.09.005</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Interest of designed cyclodextrin-tools in gene delivery<sup><xref ref-type="fn" rid="d32e884">☆</xref></sup></article-title><trans-title-group xml:lang="fr"><trans-title>Intérêt des outils cyclodextrines-modèles dans la délivrance de gènes</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name><surname>Duval</surname><given-names>R.-E.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Clarot</surname><given-names>I.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Dumarcay-Charbonnier</surname><given-names>F.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Fontanay</surname><given-names>S.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Marsura</surname><given-names>A.</given-names></name><email>alain.marsura@pharma.uhp-nancy.fr</email><xref rid="cor0005" ref-type="corresp">⁎</xref></contrib></contrib-group><aff>Laboratoire structure et réactivité des systèmes moléculaires, complexes UMR CNRS 7565, université de Lorraine, BP 70239, 54506 Vandœuvre-les-Nancy cedex, France</aff><author-notes><corresp id="cor0005"><label>⁎</label>Corresponding author. <email>alain.marsura@pharma.uhp-nancy.fr</email></corresp></author-notes><pub-date pub-type="pmc-release"><day>24</day><month>10</month><year>2012</year></pub-date><pmc-comment> PMC Release delay is 0 months and 0 days and was based on .</pmc-comment>
<pub-date pub-type="ppub"><month>11</month><year>2012</year></pub-date><pub-date pub-type="epub"><day>24</day><month>10</month><year>2012</year></pub-date><volume>70</volume><issue>6</issue><fpage>360</fpage><lpage>369</lpage><history><date date-type="received"><day>19</day><month>6</month><year>2012</year></date><date date-type="accepted"><day>22</day><month>9</month><year>2012</year></date></history><permissions><copyright-statement>Copyright © 2012 Elsevier Masson SAS. All rights reserved.</copyright-statement><copyright-year>2012</copyright-year><copyright-holder>Elsevier Masson SAS</copyright-holder><license><license-p>Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.</license-p></license></permissions><abstract><title>Summary</title><p>Cyclodextrins (CyDs) currently displays even today the image of a natural macrocyclic compound largely dominant in the formation of inclusion complexes with small hydrophobic molecules. During the past 10 years, advances in this field allowed to achieve more and more sophisticated CyDs derivatives opening a simple access in scale-up quantities to original and better CyD-based gene delivery systems. In addition, possibility to combine covalent and supramolecular approaches offers new venues for the design of tailor-made CyD-based nanovehicles to improve their transfection ability and gene transfer in cells. In this account, we describe our recent progress in the construction of a novel CyD-based G0 (generation number) core dendrimer, scalable to CyD oligomers by a strategy using protonable guanidine tethers and whose concept can be generalized for the assembly of CyD pre-coated dendrimers. The synthetic strategy based on an original Staudinger-Aza-Wittig tandem coupling reaction. We present an outline of the different analytical strategies to characterize CyD-ODN (cyclodextrin-oligodeoxynucleotide) complexes. Among them, Capillary electrophoresis (CE) was used to perfectly characterize our CyD-siRNA and CyD-DNA complexes and shown to be a very attractive method with advantages of low sample consumption, rapid analysis speed, and high efficiency that make this technology a major tool for association constant measurement. Finally, we present the different biological methods that can be used, in vitro, to study gene delivery, and more precisely ones we have performed to evaluate the capability of our original model bis-guanidinium-tetrakis-β-cyclodextrin dendrimeric tetrapod, to deliver efficiently DNA or siRNA in eukaryotic cells.</p></abstract><trans-abstract xml:lang="fr"><title>Résumé</title><p>Les cyclodextrines (CyDs) présentent encore aujourd’hui l’image de composés macrocycliques naturels largement dominants dans la formation de complexes d’inclusion avec de petites molécules hydrophobes. La possibilité de combiner des approches covalentes et supramoléculaire offre de nouveaux espaces pour la conception de nanovéhicules sur base CyDs, taillés sur mesure visant à améliorer la capacité de transfection et de transfert de gène dans les cellules. Dans cet article, nous décrivons nos récents progrès dans la construction d’un nouveau dendrimère G0 (nombre de niveaux) à base CyD. Le concept choisi étant extensible à des analogues d’ordre supérieur pour l’ensemble des dendrimères de CyDs. La stratégie de synthèse est basée sur une réaction de couplage tandem <italic>Staudinger-Aza-Wittig</italic> originale. Par ailleurs, nous présenterons un aperçu des différentes stratégies analytiques pour caractériser les complexes supramoléculaires Cyclodextrines-OligoDesoxyNucléotides (CyD-ODN). Parmi elles, l’électrophorèse capillaire (EC), une méthode très attractive avec des nombreux avantages et utilisée pour la caractérisation de nos complexes CyD-siARN et Cyd-ADN. Enfin, nous présentons les différentes méthodes biologiques qui peuvent être utilisées, in vitro, pour étudier la transfection de gènes et plus précisément celles que nous avons utilisées afin d’évaluer la capacité de notre tétrapode dendrimérique à transférer efficacement l’ADN et un siRNA dans des cellules eucaryotes.</p></trans-abstract><kwd-group><title>Keywords</title><kwd>Cyclodextrin</kwd><kwd>Dendrimers</kwd><kwd>Capillary electrophoresis</kwd><kwd>Transfection</kwd><kwd>SiRNA</kwd></kwd-group><kwd-group xml:lang="fr"><title>Mots clés</title><kwd>Cyclodextrine</kwd><kwd>Dendrimère</kwd><kwd>Électrophorèse capillaire</kwd><kwd>Transfection</kwd><kwd>ARNsi</kwd></kwd-group></article-meta></front></pmc></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/CovidV2/Data/Pmc/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000805 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Pmc/Curation/biblio.hfd -nk 000805 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= CovidV2
|flux= Pmc
|étape= Curation
|type= RBID
|clé= PMC:7094360
|texte= Interest of designed cyclodextrin-tools in gene delivery☆
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Pmc/Curation/RBID.i -Sk "pubmed:23177563" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Pmc/Curation/biblio.hfd \
| NlmPubMed2Wicri -a CovidV2
| This area was generated with Dilib version V0.6.33. |  |